Catalent Inc (CTLT)
56.45
-0.03
(-0.05%)
USD |
NYSE |
Mar 28, 16:00
56.49
+0.04
(+0.07%)
Pre-Market: 20:00
Catalent Cash from Investing (TTM): -410.00M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -410.00M |
September 30, 2023 | -923.00M |
June 30, 2023 | -955.00M |
March 31, 2023 | -1.228B |
December 31, 2022 | -1.309B |
September 30, 2022 | -1.833B |
June 30, 2022 | -1.884B |
March 31, 2022 | -1.703B |
December 31, 2021 | -1.594B |
September 30, 2021 | -665.00M |
June 30, 2021 | -649.00M |
March 31, 2021 | -598.20M |
December 31, 2020 | -981.80M |
September 30, 2020 | -893.10M |
June 30, 2020 | -827.00M |
March 31, 2020 | -1.917B |
December 31, 2019 | -1.500B |
September 30, 2019 | -1.429B |
June 30, 2019 | -1.51B |
March 31, 2019 | -316.50M |
December 31, 2018 | -302.40M |
September 30, 2018 | -1.042B |
Date | Value |
---|---|
June 30, 2018 | -919.30M |
March 31, 2018 | -912.50M |
December 31, 2017 | -996.20M |
September 30, 2017 | -237.10M |
June 30, 2017 | -309.00M |
March 31, 2017 | -286.90M |
December 31, 2016 | -193.70M |
September 30, 2016 | -219.10M |
June 30, 2016 | -137.70M |
March 31, 2016 | -139.30M |
December 31, 2015 | -157.90M |
September 30, 2015 | -260.30M |
June 30, 2015 | -271.80M |
March 31, 2015 | -300.80M |
December 31, 2014 | -281.60M |
September 30, 2014 | -189.70M |
June 30, 2014 | -171.20M |
March 31, 2014 | -148.30M |
December 31, 2013 | -155.50M |
September 30, 2013 | -123.70M |
June 30, 2013 | -122.10M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-1.917B
Minimum
Mar 2020
-316.50M
Maximum
Mar 2019
-1.156B
Average
-1.105B
Median
Cash from Investing (TTM) Benchmarks
Eli Lilly and Co | -7.153B |
Merck & Co Inc | -14.08B |
Elanco Animal Health Inc | -169.00M |
Moderna Inc | 4.206B |
Avrobio Inc | 85.08M |